UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 148

Sortiert nach

Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial

BMC medicine, 2023-06, Vol.21 (1), p.226-226, Article 226

2023

Volltextzugriff (PDF)

Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients

Journal of translational medicine, 2019-01, Vol.17 (1), p.27-27, Article 27

2019

Volltextzugriff (PDF)

The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study

BMC cancer, 2024-07, Vol.24 (1), p.1-10, Article 915

2024

Volltextzugriff (PDF)

Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER database

BMJ open, 2022-02, Vol.12 (2), p.e054135-e054135

2022

Volltextzugriff (PDF)

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody

Breast (Edinburgh), 2023-12, Vol.72, p.103597-103597, Article 103597

2023

Volltextzugriff (PDF)

Skp2 modulates proliferation, senescence and tumorigenesis of glioma

Cancer cell international, 2020-03, Vol.20 (1), p.71-71, Article 71

2020

Volltextzugriff (PDF)

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance

EBioMedicine, 2018-06, Vol.32, p.111-118

2018

Volltextzugriff (PDF)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers

Frontiers in genetics, 2020-08, Vol.11, p.829-829

2020

Volltextzugriff (PDF)

Nomogram for Predicting Chemotherapy-Induced Nausea and Vomiting for Breast Cancer Patients

The Tohoku Journal of Experimental Medicine, 2021, Vol.254(2), pp.111-121

2021

Volltextzugriff (PDF)

AI-link omnipotent pathological robot: Bridging medical meta-universe to real-world diagnosis and therapy

Innovation (New York, NY), 2023-09, Vol.4 (5), p.100494-100494, Article 100494

2023

Volltextzugriff (PDF)

Corrigendum to “Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer” [Translational Oncology (2019) 12, 764–774]

Translational oncology, 2021-12, Vol.14 (12), p.101226-101226, Article 101226

2021

Volltextzugriff (PDF)

FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920915305-1758835920915305

2020

Volltextzugriff (PDF)

Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer

Translational oncology, 2019-05, Vol.12 (5), p.764-774

2019

Volltextzugriff (PDF)

ApoG2, a novel inhibitor of antiapoptotic Bcl‐2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts

International journal of cancer, 2008-11, Vol.123 (10), p.2418-2429

2008

Volltextzugriff (PDF)

ANGPTL3: a novel biomarker and promising therapeutic target

Journal of drug targeting, 2019-09, Vol.27 (8), p.876-884

2019

Volltextzugriff (PDF)

Case report: Pilomatrix carcinoma with PDL1 expression and CDKN2A aberrant

Frontiers in immunology, 2024-05, Vol.15, p.1337400

2024

Volltextzugriff (PDF)

Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020-02, Vol.1865 (2), p.158547-158547, Article 158547

2020

Volltextzugriff (PDF)

ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway

Journal of translational medicine, 2009-08, Vol.7 (1), p.74-74, Article 74

2009

Volltextzugriff (PDF)

Long non-coding RNA-SRA promotes neointimal hyperplasia and vascular smooth muscle cells proliferation via MEK-ERK-CREB pathway

Vascular pharmacology, 2019-05, Vol.116, p.16-23

2019

Volltextzugriff (PDF)

PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies

Aging (Albany, NY.), 2020-01, Vol.12 (2), p.1577-1590

2020

Volltextzugriff (PDF)

Promoting effects of isobavachin on neurogenesis of mouse embryonic stem cells were associated with protein prenylation

Acta pharmacologica Sinica, 2011-04, Vol.32 (4), p.425-432

2011

Volltextzugriff (PDF)

Genistein Protects H9c2 Cardiomyocytes against Chemical Hypoxia-Induced Injury via Inhibition of Apoptosis

Pharmacology, 2019-04, Vol.103 (5-6), p.282-290

2019

Volltextzugriff (PDF)

Glycolytic genes in cancer cells are more than glucose metabolic regulators

Journal of molecular medicine (Berlin, Germany), 2014-08, Vol.92 (8), p.837-845

2014

Volltextzugriff (PDF)

Altered DMN functional connectivity and regional homogeneity in partial epilepsy patients: a seventy cases study

Oncotarget, 2017-10, Vol.8 (46), p.81475-81484

2017

Volltextzugriff (PDF)

Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor

Clinical breast cancer, 2018-10, Vol.18 (5), p.e1149-e1163

2018

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(140)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial

Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients

The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study

Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER database

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody

Skp2 modulates proliferation, senescence and tumorigenesis of glioma

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers

Nomogram for Predicting Chemotherapy-Induced Nausea and Vomiting for Breast Cancer Patients

AI-link omnipotent pathological robot: Bridging medical meta-universe to real-world diagnosis and therapy

Corrigendum to “Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer” [Translational Oncology (2019) 12, 764–774]

FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients

Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer

ApoG2, a novel inhibitor of antiapoptotic Bcl‐2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts

ANGPTL3: a novel biomarker and promising therapeutic target

Case report: Pilomatrix carcinoma with PDL1 expression and CDKN2A aberrant

Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis

ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway

Long non-coding RNA-SRA promotes neointimal hyperplasia and vascular smooth muscle cells proliferation via MEK-ERK-CREB pathway

PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies

Promoting effects of isobavachin on neurogenesis of mouse embryonic stem cells were associated with protein prenylation

Genistein Protects H9c2 Cardiomyocytes against Chemical Hypoxia-Induced Injury via Inhibition of Apoptosis

Glycolytic genes in cancer cells are more than glucose metabolic regulators

Altered DMN functional connectivity and regional homogeneity in partial epilepsy patients: a seventy cases study

Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor

Suchergebnisse filtern